These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24856786)

  • 21. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP
    N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041
    [No Abstract]   [Full Text] [Related]  

  • 23. Quenching the quorum sensing system: potential antibacterial drug targets.
    Kalia VC; Purohit HJ
    Crit Rev Microbiol; 2011 May; 37(2):121-40. PubMed ID: 21271798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Has nature already identified all useful antibacterial targets?
    Bumann D
    Curr Opin Microbiol; 2008 Oct; 11(5):387-92. PubMed ID: 18804175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are pleuromutilin antibiotics finally fit for human use?
    Novak R
    Ann N Y Acad Sci; 2011 Dec; 1241():71-81. PubMed ID: 22191527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW
    J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of Antibiotics.
    Kalesse M; Böhm A; Kipper A; Wandelt V
    Curr Top Microbiol Immunol; 2016; 398():419-445. PubMed ID: 27704271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial agents, bacterial resistance, and susceptibility tests.
    Dziarski R; Axler DA
    J Am Podiatr Med Assoc; 1985 Feb; 75(2):66-82. PubMed ID: 3884771
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxazolidinones: new antibacterial agents.
    Ford CW; Hamel JC; Stapert D; Moerman JK; Hutchinson DK; Barbachyn MR; Zurenko GE
    Trends Microbiol; 1997 May; 5(5):196-200. PubMed ID: 9160508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibacterial activity of tobramycin].
    Acar JF
    Nouv Presse Med; 1974 Apr; 3(0):57-9. PubMed ID: 4600179
    [No Abstract]   [Full Text] [Related]  

  • 33. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of antibacterial resistance.
    Hickey SM; Nelson JD
    Adv Pediatr; 1997; 44():1-41. PubMed ID: 9265966
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacterial sensitivity to chemotherapeutic agents (Zurich, 1990)].
    Wüst J; Kayser FH
    Schweiz Rundsch Med Prax; 1991 Sep; 80(37):946-53. PubMed ID: 1925214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial susceptibility testing in the clinical laboratory.
    Holland TL; Woods CW; Joyce M
    Infect Dis Clin North Am; 2009 Dec; 23(4):757-90, vii. PubMed ID: 19909884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial drug discovery in the 21st century.
    Bush K
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic bacteria: how to get them back into the line of fire?
    Keck W; Hubschwerlen C
    Curr Opin Investig Drugs; 2005 Feb; 6(2):139-40. PubMed ID: 15751735
    [No Abstract]   [Full Text] [Related]  

  • 39. A brief history of antibiotics.
    Johns Hopkins Med Lett Health After 50; 1999 Jul; 11(5):7. PubMed ID: 10377911
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bacterial susceptibility to chemotherapeutic agents (Zurich, 1987)].
    Wüst J; Kayser FH
    Schweiz Rundsch Med Prax; 1989 Jun; 78(26):745-50. PubMed ID: 2756266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.